News | Neuro Imaging | September 04, 2019

Findings from MU study could help identify people at risk

Neurological Brain Markers Might Detect Risk for Psychotic Disorders

Researchers at the University of Missouri used MRI scans similar to this photo to find neurological markers in the human brain. These markers can be used to detect people at risk for developing psychotic disorders and to understand when this risk has been successfully treated. Image courtesy of Marquette University/John Kerns.


September 4, 2019 — Help may be on the way for people who might lose contact with reality through a psychotic disorder, such as schizophrenia.

People who may hear and see things that are not there could have symptoms of psychosis, better known as psychotic disorders. Now, researchers at the University of Missouri have found neurological markers in the human brain that can be used to detect people at-risk for developing psychotic disorders and to understand when this risk has been successfully treated.

“Psychotic disorders like schizophrenia are often lifelong and disabling for individuals,” said John Kerns, professor of psychology in the MU College of Arts and Science. “These disorders have major public health and societal costs greater than cancer. A major goal of our current research is to understand the nature of psychosis risk so we can prevent years of suffering.”

Researchers said psychotic disorders are associated with increased levels of dopamine — a chemical released by nerve cells — in a subregion of the brain called the striatum. This area is wired to process positive versus negative feedback for learning, often resulting in a person’s thoughts and actions based on what they’ve experienced in the past. Therefore, researchers suggest that psychotic disorders involve a faulty feedback in learning that then drives a person’s faulty beliefs and perceptions. However, measuring levels of dopamine in people is costly, invasive and not feasible in everyday clinical practice. In this new study, MU researchers used magnetic resonance imaging (MRI) at MU’s Brain Imaging Center and found that people at risk for psychotic disorders exhibit evidence of dysfunction in the striatum.

“This dysfunction is most evident when performing tasks where people need to learn from positive and negative feedback,” Kerns said. “For instance, we have found that the risk for psychotic disorders involves increased activation in the striatum for positive feedback, and negative feedback involves decreased activation in the same subregion of the brain.”

Researchers believe this pattern of activation could explain symptoms of psychotic disorders. For example, activation resulting from increased positive feedback could make a person’s assumption seem truer than it really is; meanwhile, activation from decreased negative feedback could make someone less likely to discard negative ideas. The team will conduct future research to examine how well an MRI can predict the risk of psychotic disorders and whether prevention treatments can ‘normalize’ MRI scans. They hope that their research will help prevent psychotic disorders, improve the lives of millions of people and greatly reduce public health costs.

The study, “Striatum-related functional activation during reward versus punishment based learning in psychosis risk”, was published in Neuropsychopharmacology.1 

For more information: www.nature.com/npp

 

Reference

1. Karcher N.R., Hua J.P.Y., Kerns J.G. Striatum-related functional activation during reward- versus punishment-based learning in psychosis risk. Neuropsychopharmacology, published online July 4, 2019. https://doi.org/10.1038/s41386-019-0455-z


Related Content

News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Clinical Trials

June 27, 2024 — Prenuvo, which makes whole-body MRI screening for early cancer detection and other diseases, has ...

Time June 27, 2024
arrow
News | Pediatric Imaging

June 25, 2024 — Rady Children’s Hospital-San Diego, one of the nation’s top pediatric health care systems, today ...

Time June 25, 2024
arrow
News | MRI Breast

June 12, 2024 — Royal Philips recently announced the 1,111th installation of its revolutionary BlueSeal 1.5T magnet ...

Time June 12, 2024
arrow
News | Neuro Imaging

June 12, 2024 — Brainet, a developer of cutting-edge diagnostic tools for assessing brain health, and SimonMed Imaging ...

Time June 12, 2024
arrow
Subscribe Now